Testing tauroursodeoxycholic acid for mothers with fatty liver
Part of Digestive system, Hormones & metabolism clinical trials.
This trial tests whether a supplement called TUDCA (a natural bile acid) can help mothers with fatty liver who are at higher risk of liver problems after giving birth. If you qualify, you'll take the supplement while breastfeeding, and researchers will watch your liver health and your baby's growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a mother between 18 and 45 years old and plan to breastfeed.
- You gave birth within the last 3 days (72 hours).
- You have a fatty liver condition (MASLD) diagnosed by your doctor.
- Your early breast milk sample shows a specific protein marker that may indicate liver risk.
- Your baby is healthy enough to feed by mouth, born at full term (at least 37 weeks) and weighing at least 5.5 pounds.
- You are not currently taking certain bile acid medications (like ursodiol or tauroursodiol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests new medicines for adults with fatty liver disease (MASLD) that has already caused some liver scarring. It aims to see if these drugs can help prevent the liver disease from getting worse.
This study looks at how your eating patterns (when and what you eat) relate to your metabolic health, which is how your body processes sugar and fat. If you have MASLD (a fatty liver condition) or are a new mom, you may be eligible to help researchers understand how meal timing affects health.
This trial tests a supplement called TOTUM-448 to see if it can reduce liver fat and improve heart health in people with a fatty liver condition (MASLD). If you have excess liver fat and are overweight, this study could help find new ways to manage your condition.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether following live-streamed exercise classes during pregnancy can improve liver health in women with MASLD (fatty liver disease). If you qualify, you'll join a program that may help manage your condition safely during pregnancy.
This study looks at how often liver enzyme (ALT) levels rise in women with chronic hepatitis B after they give birth, and what factors might predict this. It aims to help guide care after delivery.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease Infant Development trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.